- Treatment Options
- Inhibition of ocular angiogenesis by an adenovirus carrying the human von Hippel-Lindau tumor-suppressor gene in vivo
- Renal cell cancers: unveiling the hereditary ones and saving lives-a tailored diagnostic approach
- VHL in the COVID Era: Management Approaches and Modifications
- The FDA Drug Approval Process for Serious Medical Conditions
- Hemangioblastomas are Different than Other Brain Tumors
- Renal cell cancers: unveiling the hereditary ones and saving lives-a tailored diagnostic approach
- A focused 35-minute whole body MRI screening protocol for patients with von Hippel-Lindau disease
- Quarterly VHL Research Review - July, 2019
- ICD-10 Diseases of the Nervous System
- International statistical classification of diseases and related health problems (ICD-10) in occupational health
- WHO releases new International Classification of Diseases (ICD 11)
- RareConnect.org webinar: The importance of annual screening in patients with VHL
HellasSITES